β¨ Medicines Distribution Consents
27 OCTOBER 2005 NEW ZEALAND GAZETTE, No. 180
4557
Product:
Lipex
Active Ingredient:
Simvastatin 40mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Merck Sharp & Dohme (New Zealand) Limited
Manufacturers:
Merck & Co Inc, West Point, Pennsylvania, United States of America
Merck Sharp & Dohme UK Limited, Cramlington, Northumberland, United Kingdom
Merck Sharp and Dohme Australia Pty Limited, South Granville, New South Wales, Australia
Product:
Lipex
Active Ingredient:
Simvastatin 5mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Merck Sharp & Dohme (New Zealand) Limited
Manufacturers:
Merck & Co Inc, West Point, Pennsylvania, United States of America
Merck Sharp & Dohme UK Limited, Cramlington, Northumberland, United Kingdom
Merck Sharp and Dohme Australia Pty Limited, South Granville, New South Wales, Australia
Product:
Lipex
Active Ingredient:
Simvastatin 80mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Merck Sharp & Dohme (New Zealand) Limited
Manufacturer:
Merck Sharp & Dohme UK Limited, Cramlington, Northumberland, United Kingdom
Dated this 20th day of October 2005.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go7178
Consent to the Distribution of a New Related Product
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand
of the new related product set out in the Schedule hereto:
Schedule
Product:
Colgate Fluoride Toothpaste for Kids - Sparkling Mint Gel Ages 2-6
Active Ingredient:
Sodium monofluorophosphate 0.304%w/w equivalent to fluoride ion 400ppm
Dosage Form:
Toothpaste
New Zealand Sponsor:
Colgate-Palmolive Limited
Manufacturer:
Colgate-Palmolive Pty Limited, Labrador, Queensland, Australia
Dated this 21st day of October 2005.
MARK JACOBS, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go7180
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand
of the new medicines set out in the Schedule hereto:
Schedule
Product:
Citalopram - Rex
Active Ingredient:
Citalopram hydrobromide 12.495mg equivalent to citalopram 10mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
REX Medical Limited
Manufacturer:
Cipla Limited, Manufacturing Division, MIDC Industrial Area, Kurkumbh Village, Taluka - Daund, District - Pune, Maharashtra State, India
Product:
Citalopram - Rex
Active Ingredient:
Citalopram hydrobromide 24.99mg equivalent to citalopram 20mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
REX Medical Limited
Manufacturer:
Cipla Limited, Manufacturing Division, MIDC Industrial Area, Kurkumbh Village, Taluka - Daund, District - Pune, Maharashtra State, India
Product:
Citalopram - Rex
Active Ingredient:
Citalopram hydrobromide 49.98mg equivalent to citalopram 40mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
REX Medical Limited
Manufacturer:
Cipla Limited, Manufacturing Division, MIDC Industrial Area, Kurkumbh Village, Taluka - Daund, District - Pune, Maharashtra State, India
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2005, No 180
Gazette.govt.nz —
NZ Gazette 2005, No 180
β¨ LLM interpretation of page content
π₯
Consent to Distribution of Changed Medicine
(continued from previous page)
π₯ Health & Social Welfare20 October 2005
Medicines Act, Lipex, Simvastatin, Merck Sharp & Dohme
- DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001)
π₯ Consent to the Distribution of a New Related Product
π₯ Health & Social Welfare21 October 2005
Medicines Act, Colgate Fluoride Toothpaste, Sodium monofluorophosphate, Colgate-Palmolive
- MARK JACOBS, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001)
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social WelfareMedicines Act, Citalopram, Rex Medical, Cipla Limited